Accéder au contenu
Merck

2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5).

ChemMedChem (2012-12-12)
Rainer E Martin, Caterina Bissantz, Olivier Gavelle, Christoph Kuratli, Henrietta Dehmlow, Hans G F Richter, Ulrike Obst Sander, Shawn D Erickson, Kyungjin Kim, Sherrie Lynn Pietranico-Cole, Rubén Alvarez-Sánchez, Christoph Ullmer
RÉSUMÉ

Potency with potential: 2-Phenoxy-nicotinamides were identified as potent agonists at the GPBAR1 receptor, a target in the treatment of obesity, type 2 diabetes and metabolic syndrome. Extensive structure-activity relationship studies supported by homology modeling and docking resulted in the identification of optimized GPBAR1 agonists, potent against both human and mouse receptors, endowed with favorable physicochemical properties and good metabolic stability.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Quinoline, reagent grade, 98%